Fotivda

Fotivda is an oral medication containing tivozanib, used for targeted therapy in certain cancers. It works by inhibiting vascular endothelial growth factor receptors (VEGFR).

Fotivda is primarily used in the treatment of advanced renal cell carcinoma, a type of kidney cancer. It targets specific proteins involved in tumor blood vessel growth, helping to slow cancer progression. Patients often wonder, 'What is Fotivda used for?'—it is designed for cases where other treatments have not been effective.

Common effects of Fotivda may include fatigue, hypertension, and diarrhea. Some users also report changes in taste or appetite. These effects vary and should be discussed with a healthcare provider.

Fotivda should be handled with care, following medical guidance. It is important to avoid pregnancy while taking this medication due to potential risks. Regular monitoring may be required during treatment.

Fotivda may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. Alcohol and other substances that affect liver function should be used cautiously. Always consult a healthcare provider before combining treatments.